Ovarian cancer trials in Canada

In Canada 56 Also abroad 796

56 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Where
Toronto
Age
18 years and over
People
2,500
Run by
University Health Network, Toronto
See details and how to joinNCT03702309
Phase 2Taking people
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Where
Montreal, Québec, Toronto
Age
18 years to 130 years
People
454 worldwide
Run by
AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00
Phase 3Taking people
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
Where
Calgary, Toronto
Age
18 years and over
People
580 worldwide
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT04575935
No phaseTaking people
Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental (InterCon) Countries
Where
Toronto
Age
18 years and over
People
1,000 worldwide
Run by
AbbVie
See details and how to joinNCT07539844
Phase 3Taking people
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Where
Montreal, Québec, Sherbrooke, Winnipeg
Age
Up to 39 years
People
60 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT06513962
Phase 3Taking people
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Where
Calgary, Edmonton, Halifax, Hamilton, Kingston, London, Montreal, Ottawa, Québec, Sherbrooke, St. John's, Toronto, Vancouver, Winnipeg
People
1,780 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT03067181
No phaseTaking people
Feasibility of CALM in Patients With Ovarian Cancer
Where
Toronto
Age
18 years and over
People
50
Run by
University Health Network, Toronto
See details and how to joinNCT06459271
Phase 1/2Taking people
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Where
Edmonton, Hamilton, Montreal, Ottawa, Toronto, Vancouver
Age
18 years and over
People
1,109 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04895709
Phase 2Taking people
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Where
Montreal, Toronto
Age
8 years and over
People
254 worldwide
Run by
Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00
Phase 3Taking people
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Where
Edmonton, Hamilton, Kingston, Montreal, Québec
Age
18 years and over
People
1,100 worldwide
Run by
AstraZeneca
See details and how to joinNCT07218809 · EU 2025-520466-22-00
Phase 1Taking people
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
Where
Montreal, Toronto, Vancouver
Age
18 years and over
People
240 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06476808 · EU 2025-523067-38-01
Phase 2Taking people
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
Where
Kelowna, Montreal, Toronto
Age
18 years and over
People
37 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT04641247 · EU 2023-506618-29-00
Phase 1Taking people
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Where
Calgary, Montreal, Toronto
Age
18 years and over
People
694 worldwide
Run by
AbbVie
See details and how to joinNCT05005403
No phaseTaking people
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
Where
Kingston, Ottawa, Toronto
Age
18 years and over
People
500
Run by
University Health Network, Toronto
See details and how to joinNCT05403177
Phase 1Taking people
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Where
Montreal, Toronto
Age
18 years and over
People
52 worldwide
Run by
Senhwa Biosciences, Inc.
See details and how to joinNCT04890613
No phaseNot yet taking people in Canada
Preventing Ovarian Cancer Through Opportunistic Salpingectomy at the Time of Laparoscopic Cholecystectomy
Where
Hamilton, Langley, Vancouver
Age
35 years and over
People
240
Run by
University of British Columbia
See details and how to joinNCT07625137
Phase 2Taking people
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Where
Montreal, Toronto
Age
18 years and over
People
80 worldwide
Run by
MacroGenics
See details and how to joinNCT06730347
No phaseTaking people
Prehabilitation for Ovarian Cancer Patients
Where
Halifax
Age
18 years and over
People
108
Run by
Nova Scotia Health Authority
See details and how to joinNCT05364879
No phaseTaking people
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
Where
Edmonton
Age
18 years to 90 years
People
75
Run by
University of Alberta
See details and how to joinNCT05645510
No phaseTaking people
Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host
Where
Toronto
Age
18 years and over
People
120
Run by
University Health Network, Toronto
See details and how to joinNCT02732860
No phaseTaking people
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Where
Vancouver
Age
25 years to 50 years
People
3,000 worldwide
Run by
University Medical Center Nijmegen
See details and how to joinNCT04294927
Phase 3Not yet taking people in Canada
Trauma-Focused Managing Cancer And Living Meaningfully (CALM-TF) for Newly Diagnosed and Recurrent Ovarian Cancer
Where
Toronto
Age
18 years and over
People
300
Run by
University Health Network, Toronto
See details and how to joinNCT07286162
Phase 2Taking people
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Where
Abbotsford British Columbia, Montreal, Toronto, Vancouver
Age
18 years and over
People
230 worldwide
Run by
TORL Biotherapeutics, LLC
See details and how to joinNCT06690775 · EU 2024-517190-24-00
No phaseTaking people
Study Looking at Biomarkers in Ovarian Cancer
Where
Barrie, Hamilton, Kingston, London, Ottawa, Toronto
Age
18 years and over
People
510
Run by
University Health Network, Toronto
See details and how to joinNCT03419689
No phaseTaking people
DOvEEgene Fleur: New Uterine Sampling Tool
Where
Montreal
Age
18 years and over
People
40
Run by
McGill University
See details and how to joinNCT04258449